Teladoc Health
TDOC
421 hedge funds and large institutions have $7.28B invested in Teladoc Health in 2019 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 136 increasing their positions, 132 reducing their positions, and 29 closing their positions.
179% more first-time investments, than exits
New positions opened: 81 | Existing positions closed: 29
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
18% more capital invested
Capital invested by funds: $6.17B → $7.28B (+$1.12B)
11% more funds holding
Funds holding: 378 → 421 (+43)
3% more repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 132
6.23% less ownership
Funds ownership: 126.37% → 120.13% (-6.2%)
18% less call options, than puts
Call options by funds: $142M | Put options by funds: $173M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$150M |
| 2 |
Renaissance Technologies
New York
|
+$41.3M |
| 3 |
Morgan Stanley
New York
|
+$16.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.2M |
| 5 |
Goldman Sachs
New York
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$106M |
| 2 |
JP Morgan Chase
New York
|
-$85.2M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$47.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.9M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$29.6M |
TDOC Hedge Fund Activity: Q4 2019 in Review
421 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q4 2019, worth a combined $7.28B — up 18% from $6.17B a quarter earlier.
Buyers outnumbered sellers: 81 funds opened new TDOC positions and 29 closed out — a net gain of 52 holders — while 136 added to existing stakes and 132 trimmed.
The largest buyer was Baillie Gifford & Co, adding an estimated $150M. The largest seller was Janus Henderson Group, cutting an estimated $106M.
- 421 institutional investors held Teladoc Health (TDOC) as of Q4 2019, up from 378 in Q3 2019.
- Funds reported $7.28B of Teladoc Health stock for Q4 2019, up 18% quarter-over-quarter.
- 81 funds opened new Teladoc Health positions in Q4 2019 and 29 closed out, a net change of +52 holders.
- The largest Teladoc Health buyer in Q4 2019 was Baillie Gifford & Co, an estimated $150M added.
- The largest Teladoc Health seller in Q4 2019 was Janus Henderson Group, an estimated $106M sold.
Based on aggregated 13F filings for Q4 2019.